Log in to search using one of your social media accounts:

 

A Remarkable New Technology That Will Diminish A Global Cancer Threat
A new technology could be used to sort grain like corn/maize at high speed and take out an important toxic and carcinogenic contaminant that is a particular issue for Africa - This is being advanced by a partnership between the Swiss company B ühler and Microsoft (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - April 24, 2018 Category: Pharmaceuticals Authors: Steven Savage, Contributor Source Type: news

Changes in breast tissue increase cancer risk for older women
(Cell Press) Researchers in Norway, Switzerland, and the United States have identified age-related differences in breast tissue that contribute to older women's increased risk of developing breast cancer. The findings, published April 24 in the journal Cell Reports, may help scientists better understand how breast cells change during the aging process, enabling doctors to catch the signs of cancer earlier. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 24, 2018 Category: Cancer & Oncology Source Type: news

Increase in assisted suicide in Switzerland: did the socioeconomic predictors change? Results from the Swiss National Cohort - Steck N, Junker C, Zwahlen M.
OBJECTIVE: To determine whether the strong increase in assisted suicides in Switzerland since 2008 is linked to a shift in the socioeconomic factors associated with assisted suicide and its related diagnoses. METHODS: In a population-based longitud... (Source: SafetyLit)
Source: SafetyLit - April 23, 2018 Category: International Medicine & Public Health Tags: Research Methods, Surveillance and Codes, Models Source Type: news

Suicides of psychiatric inpatients - a systematic recording in Switzerland of the years 2000 to 2010 - Ruff F, Hemmer A, Bartsch C, Glasow N, Reisch T.
OBJECTIVE: To analyze characteristics of suicide methods of psychiatric inpatients that were carried out within and outside of psychiatric hospitals in order to identify adequate suicide prevention measures. METHODS: Data of 436 inpatient suicides ... (Source: SafetyLit)
Source: SafetyLit - April 23, 2018 Category: International Medicine & Public Health Tags: Suicide and Self-Harm Source Type: news

Amerigen and Dipharma Announce U.S. FDA Approval for Generic Miglustat 100 mg Capsules
The first generic version of Miglustat is now approved in the U.S. LYNDHURST, N.J. and CHIASSO, Switzerland, April 23rd, 2018 -- (Healthcare Sales & Marketing Network) -- Amerigen Pharmaceuticals Limited ("Amerigen") and Dipharma S.A. ("... Biopharmaceuticals, Generics, FDA, Product Launch Amerigen Pharmaceuticals, Dipharma, Miglustat, Zavesca (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 23, 2018 Category: Pharmaceuticals Source Type: news

Helsinn Group announces the FDA approval of the IV formulation of AKYNZEO(R) (fosnetupitant/ palonosetron) in the United States
Lugano, Switzerland April 20, 2018 - Helsinn, a Swiss pharmaceutical group focused on building quality cancer care products, today announces that the U.S. Food and Drug Administration (FDA) has approved the intravenous formulation of AKYNZEO® (NEPA, a ... Biopharmaceuticals, Oncology, FDA Helsinn Group, AKYNZEO, fosnetupitant, palonosetron, antiemetic (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 20, 2018 Category: Pharmaceuticals Source Type: news

How do people die in Switzerland today?
(Universit é de Gen è ve) Today, almost two thirds of deaths in Switzerland aren't unexpected. How does the cultural context specific to each linguistic region influence end-of-life decisions? Researchers from the universities of Zurich and Geneva noticed significant differences between regions. However, these differences are not always more important than those observed between these regions and the countries with which they share the same language. These results are important to help ground debates on end of life decisions on facts. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 20, 2018 Category: International Medicine & Public Health Source Type: news

FDA Approves Intravenous Formulation of Akynzeo (fosnetupitant/palonosetron) for Chemotherapy-Induced Nausea and Vomiting
Lugano, Switzerland April 20, 2018 – Helsinn, a Swiss pharmaceutical group focused on building quality cancer care products, today announces that the U.S. Food and Drug Administration (FDA) has approved the intravenous formulation of Akynzeo... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - April 20, 2018 Category: Drugs & Pharmacology Source Type: news

Yale Alumni Push Back Against Asbestos Tycoon Stephan Schmidheiny
Yale University alumni are pushing again to revoke the honorary degree given to Swiss billionaire Stephan Ernst Schmidheiny, whose asbestos-filled factories in Italy were responsible for the deaths of more than 2,000 people. Schmidheiny, 70, was sentenced to 16 years in prison and fined $15 billion in 2012 by an Italian court that found him negligent in protecting employees and nearby residents from deadly asbestos-related diseases such as mesothelioma. Schmidheiny received his honorary degree from Yale in 1996. In 2014, the university dismissed efforts by the Italy-based Asbestos Victims and Relatives Association and seve...
Source: Asbestos and Mesothelioma News - April 19, 2018 Category: Environmental Health Authors: Daniel King Source Type: news

Novartis CEO feels heat on U.S. generics, Cosentyx drop
ZURICH (Reuters) - Swiss drugmaker Novartis' first quarterly results under new CEO Vas Narasimhan have been marred by a prized psoriasis treatment that disappointed and a sharp slump in sales by its U.S. generics unit. (Source: Reuters: Health)
Source: Reuters: Health - April 19, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Reminder: Invitation to Roche ’s First Quarter Sales 2018 Audio Webcast and Conference Call
Roche will publish its Sales Results for the 1st Quarter of 2018 prior to the opening of the Swiss Stock Exchange on Thursday April 26th, 2018. (Source: Roche Investor Update)
Source: Roche Investor Update - April 19, 2018 Category: Pharmaceuticals Source Type: news

Member States to elect a new WHO Regional Director for the Eastern Mediterranean
17 April 2018, Cairo – On 19 May 2018, a Special Session of the Regional Committee for the Eastern Mediterranean will be held in Geneva, Switzerland, for the sole purpose of nominating a new Regional Director for the Eastern Mediterranean. Eight candidates have been proposed by Member States and information on each candidate is available on the Regional Office election website from where the general public can learn more about the candidates and WHO's election process.  This is the first time that detailed professional profiles of candidates have been posted on the Regional Office website and is part of reforms...
Source: WHO EMRO News - April 17, 2018 Category: Middle East Health Source Type: news

The car, the hammer and the cables under the tables: intersecting masculinities and social class in a Swiss vocational school - Moret J, D ümmler K, Dahinden J.
Based on ethnographic material, this article explores how three groups of apprentices negotiate masculinities in the specific setting of a male-dominated vocational school in Switzerland dedicated to the building trades. We use an intersectional and relati... (Source: SafetyLit)
Source: SafetyLit - April 17, 2018 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Roche's Hemlibra gets speedy FDA review for wider use
ZURICH (Reuters) - Roche's hemophilia A drug Hemlibra will get an accelerated review by U.S. regulators for use in a new group of patients, a key part of the Swiss drug company's plans to muscle in on turf dominated by rivals including Shire. (Source: Reuters: Health)
Source: Reuters: Health - April 17, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Kineta inks $360 million-plus deal with Genentech for chronic pain drug
Kineta Chronic Pain LLC has inked a drug collaboration deal with pharmaceutical giant Genentech to develop non-opioid chronic pain treatment. The Seattle-based biotech, a subsidiary of Kineta Inc., received an undisclosed upfront payment as part of the deal and is eligible for milestone payments up to $359 million as well as royalty payments. San Francisco-based Genentech has the option to license technologies developed during the col laboration. Swiss drug maker Roche bought Genentech for $46.8… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - April 16, 2018 Category: American Health Authors: Casey Coombs Source Type: news

Givaudan turns to Haitian roots for anti-wrinkle ingredient
ZURICH (Reuters) - Swiss fragrance and flavors company Givaudan has begun recycling Haitian vetiver roots now used to make oil for fragrances to produce a new cosmetic substance it said can reduce wrinkles and help scents linger longer. (Source: Reuters: Health)
Source: Reuters: Health - April 16, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Low level of vegetative state after traumatic brain injury in a Swiss academic hospital - Stretti F, Klinzing S, Ehlers U, Steiger P, Schuepbach R, Krones T, Brandi G.
BACKGROUND: No standards exist regarding decision making for comatose patients, especially concerning life-saving treatments. The aim of this retrospective, single-center study was to analyze outcomes and the decision-making process at the end of life (EOL... (Source: SafetyLit)
Source: SafetyLit - April 16, 2018 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Genetic modification will be tested for the first time in Europe to cure blood disorder
Scientists at Swiss company Crispr Therapeutics are hoping to use genetic modification to cure â-thalassemia, a devastating inherited blood disorder. (Source: the Mail online | Health)
Source: the Mail online | Health - April 15, 2018 Category: Consumer Health News Source Type: news

Alectinib provides longer symptom improvement than crizotinib in ALK-positive lung cancer
(European Society for Medical Oncology) The findings of the ALEX trial presented at the ELCC (European Lung Cancer Congress) 2018 in Geneva, Switzerland, support the use of alectinib as the new standard of care in the frontline treatment of ALK-positive lung cancer. Alectinib was found to provide longer symptom improvement than crizotinib in ALK-positive non-small-cell lung cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 12, 2018 Category: Cancer & Oncology Source Type: news

Immunotherapy provides long-term survival benefit: Further evidence in lung cancer
(European Society for Medical Oncology) Further evidence that immunotherapy provides long-term survival benefit for patients with lung cancer was presented today at ELCC 2018 (European Lung Cancer Congress) in Geneva, Switzerland.Researchers presented the three-year survival results of the randomised phase 2 POPLAR trial in second line, which is the longest follow-up reported to date with anti-programmed death ligand 1 (PD-L1) immunotherapy in patients with previously treated, advanced non-small-cell lung cancer (NSCLC). (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 12, 2018 Category: Cancer & Oncology Source Type: news

The fight for clean emissions continues
(Swiss Federal Laboratories for Materials Science and Technology (EMPA)) It is exactly 20 years since experts from Empa and VERT published the first test results on diesel particle filters. Today, more than 300 million vehicles worldwide are fitted with such filters. However, a VERT conference held at the Empa Academy revealed why the emission problem is by no means over. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 12, 2018 Category: International Medicine & Public Health Source Type: news

Lonza's Virus Factory Shows Gene Therapy's Texas-sized Promise Lonza's Virus Factory Shows Gene Therapy's Texas-sized Promise
Swiss drugmaker-for-hire Lonza is betting that trillions of customized viruses made at a giant factory in Texas will be the lucrative raw materials of a medical revolution.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 11, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Funding Roundup: Swiss Advanced Vision seeks $21m for auto-focus IOL
Funding Roundup A clutch of medical device companies raised cash to fund their operations, includingAscentX Medical, Avenda Health, Global Kinetics, Nephros, OrthoSensor and Swiss Advanced Vision. Here’s a look at them, their technologies and how much they drummed up. Next>> The post Funding Roundup: Swiss Advanced Vision seeks $21m for auto-focus IOL appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - April 11, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Endoscopic / Arthroscopic Funding Roundup Optical/Ophthalmic Orthopedics Patient Monitoring Urology AscentX Medical Avenda Health Global Kinetics Corp. Nephros Orthosensor Inc. Swiss Advanced Vision Source Type: news

Swiss biotech giant plans to hire at new 300,000 SF Pearland facility
"Definitely many more well-educated experts are needed in this place." (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - April 11, 2018 Category: American Health Authors: Jack Witthaus Source Type: news

Intense IVF may increase heart disease risk in children
A Swiss study, to be presented at the International Society for Milder Approaches to Assisted Reproduction, reports that children born using intensive IVF techniques may have a higher risk of developing heart problems later in life.The Telegraph (Source: Society for Endocrinology)
Source: Society for Endocrinology - April 10, 2018 Category: Endocrinology Source Type: news

Lonza's virus factory shows gene therapy's Texas-sized promise
ZURICH (Reuters) - Swiss drugmaker-for-hire Lonza is betting that trillions of customized viruses made at a giant factory in Texas will be the lucrative raw materials of a medical revolution. (Source: Reuters: Health)
Source: Reuters: Health - April 10, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Novartis buys US gene therapy group AveXis for $8.7bn
Deal is latest strategic move by Swiss drugmaker’s new chief executive (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - April 9, 2018 Category: Pharmaceuticals Source Type: news

Validity and predictive accuracy of the Structured Assessment of Protective Factors for Violence Risk in criminal forensic evaluations: a Swiss cross-validation retrospective study - Abbiati M, Azzola A, Palix J, Gasser J, Moulin V.
Some actuarial and structured professional judgment (SPJ) risk-assessment instruments have already demonstrated their validity and predictive accuracy in expert criminal forensic evaluations. In contrast, little is known about the effectiveness of instrume... (Source: SafetyLit)
Source: SafetyLit - April 7, 2018 Category: International Medicine & Public Health Tags: Jurisprudence, Laws, Legislation, Policies, Rules Source Type: news

Ascensia looks to expand access to blood glucose monitoring tech for UnitedHealthcare enrollees
Ascensia Diabetes Care inked a new relationship with UnitedHealthcare (NYSE:UNH), the company touted today, which is designed to improve access to Ascensia’s Contour Next blood glucose meters and test strips for UnitedHealthcare members. Now, people enrolled in UnitedHealthcare’s employer or commercial plans can get a meter or test trip through their pharmacy benefit at a Tier 2 copay level, according to the Switzerland-based company. Get the full story at our sister site, Drug Delivery Business News. The post Ascensia looks to expand access to blood glucose monitoring tech for UnitedHealthcare enroll...
Source: Mass Device - April 5, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Diabetes Patient Monitoring Wall Street Beat Ascensia Diabetes Care UnitedHealthcare Source Type: news

ACR, SBI: Some black women need earlier breast screening
The American College of Radiology (ACR) and the Society of Breast Imaging (SBI)...Read more on AuntMinnie.comRelated Reading: ACR, SBI reiterate support for annual mammograms at 40 ACR, SBI take issue with Swiss NEJM commentary ACR, SBI praise Cancer mammo screening study ACR, SBI critique AIM mammo study ACR, SBI slam BMJ study on mammo (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 4, 2018 Category: Radiology Source Type: news

How dirty rubber ducks are connected to superbugs: McMaster scientist
A recent study from Switzerland suggests that rubber duckies are potential havens for disease-carrying bacteria. An expert in infectious disease from McMaster University explains how concerned you should be about household germs. (Source: CBC | Health)
Source: CBC | Health - April 4, 2018 Category: Consumer Health News Tags: News/Canada/Hamilton Source Type: news

Pitch for Smarter Healthcare at the Roche Innovation Summit
The European Innovation Council (EIC) SME Instrument and Roche invite you to pitch your ideas and breakthroughs on healthcare tech at the Roche Innovation Summit on the 19th and 20th of June in Basel, Switzerland. On a yearly basis, Roche organises an internal Innovation summit, to inspire, connect, develop and advance their organisation. (Source: eHealth News EU)
Source: eHealth News EU - April 4, 2018 Category: Information Technology Tags: Featured Industry Business and Industry Source Type: news

Novel PET agent could advance neurological imaging
Swiss and German researchers have obtained promising results with a novel PET...Read more on AuntMinnie.comRelated Reading: Novel PET tracer may improve NSCLC patient management Novel PET agent targets copper in prostate tumors New PET radiotracer offers insight into multiple sclerosis PET plays key role in preventive Alzheimer's study New therapeutic agent could treat prostate cancer (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 3, 2018 Category: Radiology Source Type: news

NN Inc. to pay $375m for Paragon Medical
NN Inc. (NSDQ:NNBR) said today that it agreed to put up $375 million for orthopedic contract manufacturer Paragon Medical. Pierceton, Ind.-based Paragon makes orthopedic case and tray kits, implants and instruments and posted sales growth of 11.9% to $141 million last year, NN said. Paragon also has facilities in Indianapolis, Smithfield, Utah, Siechnice, Poland, Lausanne, Switzerland and Changzhou, China. NN, which is based in Johnson City, Tenn., said it expects the deal to deliver $33 million in synergies over three years, with $16 million coming during the first year after closing, expected during the se...
Source: Mass Device - April 3, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Contract Manufacturing Mergers & Acquisitions Orthopedics Wall Street Beat NN Inc. Paragon Medical Source Type: news

A Registered Nurse ’s Dispatch from Uganda
April 03, 2018In honor of World Health Worker Week 2018, health workers from around the world are telling us what it's really like on the front lines.This week, we ’re featuring personal stories from frontline health workers all over the world. It’s just one of the ways we’re celebratingWorld Health Worker Week 2018.Today ’s post featuresSamalie Kitoleko, a registered nurse who ’s using her story to advocate for policy changes that help the people in her community and in others like it.A registered nurse in UgandaOne day I went to a community to look for a young girl who was nine years —...
Source: IntraHealth International - April 2, 2018 Category: International Medicine & Public Health Authors: intrahealth Source Type: news

Stamping or Machining: What Do You Choose for Your Metal Devices?
You’re developing a metal medical device and balancing a budget, deadlines, design considerations, and more. Which process do you choose—stamping or machining? MD+DI asked metal manufacturing veteran Steve Santoro, executive vice president for Micro, to compare the two processes as well as look forward to the future in metal manufacturing. Santoro has been at Micro since 2002 and has been in the contract manufacturing industry his entire career. MSC-3087 Steve 1[1] copy.jpg Steve Santoro Image Credit:  Steve Santoro MD+DI: What are the basic differences between stamping and machining w...
Source: MDDI - March 30, 2018 Category: Medical Devices Authors: Daphne Allen Tags: BIOMEDevice Boston Contract Manufacturing Materials Source Type: news

Association of overcrowding and turnover with self-harm in a Swiss pre-trial prison - Baggio S, G étaz L, Tran NT, Peigné N, Chacowry Pala K, Golay D, Heller P, Bodenmann P, Wolff H.
Self-harm is a common issue in detention and includes both suicidal and non-suicidal behaviours. Beyond well-known individual risk factors, institutional factors such as overcrowding (i.e., when the prison population exceeds its capacity) and turnover (i.e... (Source: SafetyLit)
Source: SafetyLit - March 29, 2018 Category: International Medicine & Public Health Tags: Jurisprudence, Laws, Legislation, Policies, Rules Source Type: news

Tumor suppressor protein targets liver cancer
(Salk Institute) Salk Institute scientists, together with researchers from Switzerland's University of Basel and University Hospital Basel, discovered a protein called LHPP that acts as a molecular switch to turn off the uncontrolled growth of cells in liver cancer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 29, 2018 Category: International Medicine & Public Health Source Type: news

Some rubber ducks harbour 'potentially pathogenic bacteria'
Swiss and American researchers counted the microbes swimming inside the toys and say the murky liquid released when ducks were squeezed contained "potentially pathogenic bacteria" in four out of the five toys studied. (Source: CBC | Health)
Source: CBC | Health - March 28, 2018 Category: Consumer Health News Tags: News/World Source Type: news

Your Cute Rubber Duck May Be a Haven for Bacteria
A study of bath toys found the water inside yellow ducks swimming with microbes, including bacteria often associated with hospital infections. (Source: NYT Health)
Source: NYT Health - March 28, 2018 Category: Consumer Health News Authors: CEYLAN YEGINSU Tags: Bacteria Toys Biofilms and Microbiomes (Journal) Polymers University of Illinois Swiss Federal Institute of Aquatic Science and Technology, ETH Zurich Source Type: news

Reva touts first implant of Fantom Encore bioresorbable scaffold in Switzerland
Reva Medical (ASX:RVA) announced today that the company’s Fantom Encore bioresorbable vascular scaffold was used for the first time in Switzerland. The sirolimus-eluting device, which is made from Reva’s proprietary Tyrocore polymer, features a 95-micron strut profile and x-ray visibility. Get the full story at our sister site, Drug Delivery Business News. The post Reva touts first implant of Fantom Encore bioresorbable scaffold in Switzerland appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - March 28, 2018 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Implants Pharmaceuticals Vascular Wall Street Beat Reva Medical Inc. Source Type: news

Roche shares drop after deaths of patients taking Hemlibra
ZURICH (Reuters) - Swiss drugmaker Roche's shares dropped on Wednesday after it told U.S.-based haemophilia advocacy groups that five patients treated with its medicine Hemlibra had died, while maintaining that the therapy was not the cause of the deaths. (Source: Reuters: Health)
Source: Reuters: Health - March 28, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Tokyo court rejects Shire claim against Roche hemophilia drug
ZURICH (Reuters) - A Tokyo court has ruled that Shire's claim against Swiss drugmaker Roche's new Hemlibra hemophilia medicine should be dismissed, Roche's Japanese subsidiary Chugai said on Wednesday, helping to clear up legal uncertainty over the prospective blockbuster medicine. (Source: Reuters: Health)
Source: Reuters: Health - March 28, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Study: Bathtub toys harbor bacteria, fungal species
The rubber ducky, those yellow bath-time toys used to entertain kids, contained high numbers of bacteria and fungal species, according to a study in Switzerland. (Source: Health News - UPI.com)
Source: Health News - UPI.com - March 27, 2018 Category: Consumer Health News Source Type: news

The Adorable Rubber Ducky Is Actually a Haven for Nasty Bacteria, Scientists Say
(BERN, Switzerland) — Scientists now have the dirt on the rubber ducky: Those cute yellow bath-time toys are — as some parents have long suspected — a haven for nasty bugs. Swiss and American researchers counted the microbes swimming inside the toys and say the murky liquid released when ducks were squeezed contained “potentially pathogenic bacteria” in four out of the five toys studied. The bacteria found included Legionella and Pseudomonas aeruginosa, a bacterium that is “often implicated in hospital-acquired infections.” The study by the Swiss Federal Institute of Aquatic Scienc...
Source: TIME: Health - March 27, 2018 Category: Consumer Health News Authors: Frank Jordans and Jamey Keaten / AP Tags: Uncategorized APH healthytime onetime public health Source Type: news

Your rubber duck is riddled with bacteria
Researchers from Swiss Federal Institute of Aquatic Science and Technology found toys that can squirt water can contain pathogens, including drug-resistant superbugs, that can be deadly. (Source: the Mail online | Health)
Source: the Mail online | Health - March 27, 2018 Category: Consumer Health News Source Type: news

Hormone treatment burns post-menopausal belly fat
Women who take hormone replacement therapies to ease the symptoms of menopause weigh slightly less and have significantly less belly fat - so long as they keep up the drugs, a new Swiss study reveals. (Source: the Mail online | Health)
Source: the Mail online | Health - March 27, 2018 Category: Consumer Health News Source Type: news

Beware of your rubber duck: The popular bathroom companion is riddled with bacteria
Researchers from Swiss Federal Institute of Aquatic Science and Technology found toys that can squirt water can contain pathogens, including drug-resistant superbugs, that can be deadly. (Source: the Mail online | Health)
Source: the Mail online | Health - March 27, 2018 Category: Consumer Health News Source Type: news

Novartis and GSK CEOs set out diverging strategies
Swiss group focuses on pharma as $13bn deal hands UK partner control of consumer unit (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - March 27, 2018 Category: Pharmaceuticals Source Type: news

Novartis sells stake in consumer business to GSK for $13bn
Swiss group’s new chief sheds consumer health unit to focus on pharmaceuticals (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - March 27, 2018 Category: Pharmaceuticals Source Type: news